{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:17:51Z","timestamp":1774333071649,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["2015305"],"award-info":[{"award-number":["2015305"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jtha.2023.10.027","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T02:54:37Z","timestamp":1699325677000},"page":"785-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activation"],"prefix":"10.1016","volume":"22","author":[{"given":"Charithani B.","family":"Keragala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"McFadyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona M.","family":"McCutcheon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zikou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Monagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Chunilal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Medcalf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huyen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.10.027_bib1","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.10.027_bib2","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.10.027_bib3","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.10.027_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/bjh.17750","article-title":"Activation of circulating platelets in vaccine-induced thrombotic thrombocytopenia and its reversal by intravenous immunoglobulin","volume":"196","author":"McFadyen","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.10.027_bib5","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.027_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5694\/mja2.51229","article-title":"Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia","volume":"215","author":"Chen","year":"2021","journal-title":"Med J Aust"},{"key":"10.1016\/j.jtha.2023.10.027_bib8","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMc2112974","article-title":"Vaccine-induced thrombocytopenia with severe headache","volume":"385","author":"Salih","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.10.027_bib9","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/bloodadvances.2021006698","article-title":"A\u00a0novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia","volume":"6","author":"Lee","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.10.027_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.589628","article-title":"Plasmin generation potential and recanalization in acute ischaemic stroke; an observational cohort study of stroke biobank samples","volume":"11","author":"Lillicrap","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.jtha.2023.10.027_bib11","first-page":"204","article-title":"Formation, inhibition and clearance of plasmin in\u00a0vivo","volume":"30","author":"Chandler","year":"2000","journal-title":"Haemostasis"},{"key":"10.1016\/j.jtha.2023.10.027_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood.V53.2.313.313","article-title":"Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma","volume":"53","author":"Collen","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.027_bib13","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood-2009-02-203448","article-title":"A\u00a0nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury","volume":"114","author":"Samson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.027_bib14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.celrep.2012.08.026","article-title":"Nucleocytoplasmic coagulation: an injury-induced aggregation event that disulfide crosslinks proteins and facilitates their removal by plasmin","volume":"2","author":"Samson","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtha.2023.10.027_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.10.027_bib16","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.10.027_bib17","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.ajem.2018.01.048","article-title":"D-dimer and thrombus burden in acute pulmonary embolism","volume":"36","author":"Keller","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jtha.2023.10.027_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.thromres.2006.08.006","article-title":"D-dimer level is associated with the extent of pulmonary embolism","volume":"120","author":"Ghanima","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.10.027_bib19","first-page":"CD010864","article-title":"D-dimer test for excluding the diagnosis of pulmonary embolism","volume":"2016","author":"Crawford","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2023.10.027_bib20","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1074\/jbc.272.4.2183","article-title":"A\u00a0steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain","volume":"272","author":"Horrevoets","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.10.027_bib21","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/S0021-9258(19)81051-7","article-title":"Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin","volume":"257","author":"Hoylaerts","year":"1982","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.10.027_bib22","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.febslet.2009.06.013","article-title":"Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors)","volume":"583","author":"Gebbink","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jtha.2023.10.027_bib23","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1074\/jbc.M208894200","article-title":"Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells","volume":"278","author":"Nassar","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.10.027_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6883","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT) after SARS-CoV-2 vaccination: two cases from Germany with unusual presentation","volume":"11","author":"Edmonds","year":"2023","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.jtha.2023.10.027_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.seminhematol.2022.02.002","article-title":"Epidemiology of VITT","volume":"59","author":"Pai","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtha.2023.10.027_bib26","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.jtha.2023.09.007","article-title":"Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis","volume":"21","author":"Simpson","year":"2023","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623007973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623007973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:42:00Z","timestamp":1761536520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623007973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1538783623007973"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.10.027","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activation","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}